| # | Drug | Count |
|---|---|---|
| 0 | OXYCODONE HYDROCHLORIDE | 54 |
| 1 | OXYCODONE | 43 |
| 2 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 31 |
| 3 | FENTANYL | 27 |
| 4 | ALCOHOL | 18 |
| 5 | ETHYL ALCOHOL | 18 |
| 6 | ISOPROPYL ALCOHOL | 18 |
| 7 | ALPRAZOLAM | 17 |
| 8 | DRONABINOL | 16 |
| 9 | BUPRENORPHINE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DRONABINOL | 16 | 0.0020 |
| 1 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 31 | 0.0013 |
| 2 | NITROUS OXIDE | 2 | 0.0009 |
| 3 | BUPRENORPHINE AND NALOXONE | 1 | 0.0008 |
| 4 | ETHYL ALCOHOL | 18 | 0.0007 |
| 5 | ISOPROPYL ALCOHOL | 18 | 0.0005 |
| 6 | ALCOHOL | 18 | 0.0005 |
| 7 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | 1 | 0.0004 |
| 8 | ETEPLIRSEN | 1 | 0.0004 |
| 9 | FENTANYL | 27 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Opioid Agonist [EPC] | 27 |
| 1 | Benzodiazepine [EPC] | 23 |
| 2 | Cannabinoid [EPC] | 16 |
| 3 | Central Nervous System Stimulant [EPC] | 16 |
| 4 | Partial Opioid Agonist [EPC] | 13 |
| 5 | Central alpha-2 Adrenergic Agonist [EPC] | 3 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3 |
| 7 | Atypical Antipsychotic [EPC] | 2 |
| 8 | Cholinergic Nicotinic Agonist [EPC] | 2 |
| 9 | Corticosteroid [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cannabinoid [EPC] | 16 | 0.0020 |
| 1 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 2 | Central Nervous System Stimulant [EPC] | 16 | 0.0002 |
| 3 | Partial Opioid Agonist [EPC] | 13 | 0.0001 |
| 4 | Opioid Agonist [EPC] | 27 | 0.0001 |
| 5 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |
| 6 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 7 | Central alpha-2 Adrenergic Agonist [EPC] | 3 | 0.0001 |
| 8 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 9 | Muscle Relaxant [EPC] | 2 | 0.0000 |